Nadler Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$772K Buy
6,005
+152
+3% +$17.8K 0.07% 65
2026
Q1
$704K Buy
5,853
+43
+0.7% +$4.96K 0.07% 65
2025
Q4
$612K Sell
5,810
-95
-2% -$8.92K 0.06% 66
2025
Q3
$496K Buy
5,905
+111
+2% +$9.14K 0.05% 81
2025
Q2
$459K Buy
5,794
+11
+0.2% +$874 0.05% 78
2025
Q1
$519K Sell
5,783
-996
-15% -$93K 0.06% 72
2024
Q4
$674K Sell
6,779
-117
-2% -$12.1K 0.07% 58
2024
Q3
$783K Buy
6,896
+632
+10% +$75.1K 0.09% 53
2024
Q2
$775K Buy
6,264
+7
+0.1% +$902 0.09% 50
2024
Q1
$826K Sell
6,257
-496
-7% -$61.1K 0.1% 51
2023
Q4
$736K Buy
6,753
+222
+3% +$23K 0.1% 51
2023
Q3
$672K Buy
6,531
+8
+0.1% +$862 0.1% 53
2023
Q2
$753K Buy
6,523
+6
+0.1% +$681 0.11% 54
2023
Q1
$693K Sell
6,517
-193
-3% -$20.8K 0.11% 55
2022
Q4
$744K Sell
6,710
-22
-0.3% -$2.25K 0.13% 51
2022
Q3
$580K Sell
6,732
-22
-0.3% -$1.96K 0.11% 52
2022
Q2
$616K Buy
6,754
+533
+9% +$47.3K 0.11% 56
2022
Q1
$510K Sell
6,221
-384
-6% -$30.3K 0.08% 65
2021
Q4
$506K Sell
6,605
-551
-8% -$43.9K 0.07% 71
2021
Q3
$537K Buy
7,156
+10
+0.1% +$761 0.09% 68
2021
Q2
$556K Sell
7,146
-785
-10% -$58.4K 0.09% 68
2021
Q1
$583K Sell
7,931
-1,013
-11% -$74.7K 0.1% 63
2020
Q4
$698K Sell
8,944
-206
-2% -$15.8K 0.13% 55
2020
Q3
$724K Buy
9,150
+958
+12% +$75K 0.16% 48
2020
Q2
$604K Buy
8,192
+8
+0.1% +$602 0.15% 47
2020
Q1
$601K Sell
8,184
-1,828
-18% -$144K 0.18% 42
2019
Q4
$869K Buy
10,012
+1,828
+22% +$150K 0.21% 42
2019
Q3
$657K Buy
8,184
+72
+0.9% +$5.77K 0.18% 43
2019
Q2
$649K Buy
8,112
+309
+4% +$23.7K 0.19% 43
2019
Q1
$619K Buy
7,803
+392
+5% +$29.3K 0.2% 45
2018
Q4
$540K Buy
7,411
+6
+0.1% +$424 0.18% 45
2018
Q3
$501K Sell
7,405
-272
-4% -$17.3K 0.14% 52
2018
Q2
$445K Buy
7,677
+141
+2% +$7.96K 0.13% 53
2018
Q1
$392K Sell
7,536
-1,167
-13% -$63K 0.12% 53
2017
Q4
$467K Buy
8,703
+287
+3% +$15.9K 0.14% 50
2017
Q3
$514K Sell
8,416
-257
-3% -$15.6K 0.17% 45
2017
Q2
$530K Sell
8,673
-1,288
-13% -$78.4K 0.18% 46
2017
Q1
$604K Sell
9,961
-1,389
-12% -$84.3K 0.21% 43
2016
Q4
$638K Buy
11,350
+761
+7% +$44.5K 0.24% 39
2016
Q3
$631K Buy
10,589
+374
+4% +$21.9K 0.25% 38
2016
Q2
$562K Buy
10,215
+7
+0.1% +$373 0.24% 41
2016
Q1
$515K Buy
10,208
+218
+2% +$10.7K 0.23% 44
2015
Q4
$503K Sell
9,990
-111
-1% -$5.6K 0.23% 42
2015
Q3
$476K Buy
10,101
+7
+0.1% +$372 0.24% 40
2015
Q2
$548K Sell
10,094
-757
-7% -$42.5K 0.26% 36
2015
Q1
$595K Sell
10,851
-83
-0.8% -$4.7K 0.29% 33
2014
Q4
$592K Buy
10,934
+1,074
+11% +$59.8K 0.31% 32
2014
Q3
$558K Buy
9,860
+725
+8% +$40.7K 0.33% 32
2014
Q2
$504K Buy
9,135
+60
+0.7% +$3.27K 0.32% 31
2014
Q1
$492K Sell
9,075
-779
-8% -$40.3K 0.33% 34
2013
Q4
$471K Sell
9,854
-34
-0.3% -$1.55K 0.3% 37
2013
Q3
$449K Sell
9,888
-3,456
-26% -$158K 0.33% 42
2013
Q2
$591K Buy
+13,344
New +$596K 0.42% 36

Other funds holding MRK

Nadler Financial Group's MRK Position: Q2 2026 in Review

Nadler Financial Group increased its Merck (MRK) stake by 2.6% in Q2 2026, buying an estimated $17.8K and bringing the position to 6,005 shares worth $772K. The position accounts for 0.07% of the portfolio, ranked #65.

Nadler Financial Group first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $869K in Q4 2019. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Nadler Financial Group held 6,005 shares of Merck worth $772K as of Q2 2026.
  • Nadler Financial Group bought 152 Merck shares in Q2 2026, an estimated $17.8K.
  • Merck made up 0.07% of Nadler Financial Group's portfolio in Q2 2026, its #65 holding.
  • Nadler Financial Group first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Nadler Financial Group's Merck position peaked at $869K in Q4 2019.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Nadler Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.